Voloridge Investment Management, LLC Immunovant, Inc. Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $2.14 Million - $3.58 Million	-150,774 Reduced 38.93%	236,543 $4.49 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $2.77 Million - $3.58 Million	181,483 Added 88.17%	387,317 $6.01 Million
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $1.36 Million - $3.65 Million	205,834 New	205,834 $3.65 Million
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $912,798 - $1.58 Million	-180,395 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $1.36 Million - $1.73 Million	-185,398 Reduced 50.68%	180,395 $1.54 Million
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $20,581 - $33,382	-2,936 Reduced 0.8%	365,793 $3.18 Million
Q2 2021 Aug 16, 2021	SELL	$9.4 - $16.85 $576,088 - $1.03 Million	-61,286 Reduced 14.25%	368,729 $3.9 Million
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $5.62 Million - $21.3 Million	430,015 New	430,015 $6.9 Million

211

66M

2.3M

631K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.